Trademark Overview
On Thursday, July 25, 2024, a trademark application was filed for AUTO-T with the United States Patent and Trademark Office. The USPTO has given the AUTO-T trademark a serial number of 98667079. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, June 13, 2025. This trademark is owned by National Resilience, Inc.. The AUTO-T trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology; providing technical information about biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins
Research and development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; design and development of technology platforms, namely, biomanufacturing relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; provision of information relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceut...
